Successful treatment of a patient with octreotide–resistant necrolytic migratory erythema
- 1 June 1996
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 134 (6), 1101-1104
- https://doi.org/10.1111/j.1365-2133.1996.tb07951.x
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Treatment of necrolytic migratory erythema in glucagonoma syndromeJournal of the American Academy of Dermatology, 1991
- Necrolytic migratory erythema without glucagonoma: the role of dietary essential fatty acidsBritish Journal of Dermatology, 1991
- Necrolytic migratory erythema without glucagonoma versus canine superficial necrolytic dermatitis: Is hepatic impairment a clue to pathogenesis?Journal of the American Academy of Dermatology, 1991
- (19) Necrolytic migratory erythema: apparent response to oral omega-3 (marine) essential fatty acidsBritish Journal of Dermatology, 1990
- Glucagonoma syndrome: In vitro evidence that glucagon increases epidermal arachidonic acidJournal of the American Academy of Dermatology, 1984
- Plasma enteroglucagon related to malabsorption in coeliac disease.Gut, 1984
- Unique association of necrolytic migratory erythema, extensive angioplasia, and high molecular weight glucagon-like polypeptideThe American Journal of Dermatopathology, 1982
- Nutritional and hormonal factors influencing desaturation of essential fatty acidsProgress in Lipid Research, 1981
- Clinical and Metabolic Aspects of GlucagonomaMedicine, 1980
- A GLUCAGONOMA SYNDROMEThe Lancet, 1974